GSK, NIH Experimental Ebola Vaccine Clinical Trial Slated to Start Next Week

The National Institutes of Health -- following an expedited sign off from FDA -- next week will start testing in humans a vaccine intended to prevent the Ebola virus, NIH said Thursday (Aug. 28). The NIH study, which will start at the NIH Clinical Center in Bethesda, MD, is part of a multi-pronged international study that also will be launched in the United Kingdom and West African countries in the coming months. NIH said the pace of human safety testing...